top of page

China delivers hope to rare disease patients

Writer: Chris McMillan
Chris McMillan
Mar 3, 2025
1 min read

China Daily


28th February 2025


China delivers hope to rare disease patients


When Ms. Liu, a cancer patient, picked up a box of medication at the hospital pharmacy, she felt an overwhelming sense of relief.


She had just become the first person in China to receive a prescription for Mitotane, the only drug approved for treating adrenocortical carcinoma -- a rare, aggressive cancer that affects the adrenal glands.


Just 48 hours after Mitotane was approved for marketing in the Chinese mainland on Jan. 7, the drug arrived at Peking Union Medical College Hospital (PUMCH), a national leader in rare disease diagnosis and treatment.


Recent Posts

See All
Zhongshan Ophthalmic Center, Sun Yat-sen University

Zhongshan Ophthalmic Center, Sun Yat-sen University 11th September 2026 Zhongshan Ophthalmic Center, Sun Yat-sen University shares China's eye health practices at WHO SPECS 2030 meeting Written and Ed

 
 
 
Plan to boost special education nationally

China Daily 9th September 2026 Plan to boost special education nationally Focus on building inclusive, accessible system for children with disabilities A new action plan, released by China's Ministry

 
 
 

Comments


© 2021 China Vision (Charity Registration No.1078606)

bottom of page